Abstract:OBJECTIVE:To evaluate the possibility and efficiency of nanoparticle as a new vector in vascular endothelial growth factor (VEGF) gene transference, and investigate the efficacy of direct gene transfer of nanoparticle with VEGF(165) gene into ischemic myocardium.METHODS:Nanoparticle-VEGF (Np/VEGF) complex was prepared with poly (D, L-lactide-co-glycolide) (PLGA) loading VEGF(165) gene and the envelopment efficiency and size of the complex were determined. The Np/VEGF was transfected into the cultured myocardial cells, RT-PCR and ELISA were used to evaluate the transfection of VEGF. Suspension of Np/VEGF was injected into the myocardial tissue of 4 rabbits. 96 hours after operation myocardial tissue was obtained, made into sections, and observed with electron microscope. New Zealand White rabbits underwent thoracotomy followed by ligation of left anterior descending coronary artery to establish ischemic models. The New Zealand White rabbits were divided into 3 groups: Np/VEGF group (n = 12, nanoparticle with VEGF(165) were injected into the cordial myocardium), blank plasmid group (n = 12, injected with blank VEGF(165) plasmid), and control group (n = 8, injected with normal saline). Ultrasonography and immunohistochemistry with factor VIII related antigen were conducted to evaluate the cardiac function and the collateral circulation of the occluded artery. One month later the rabbits were killed to observe the vascularization of capillaries in the ischemic myocardium.RESULTS:The envelopment efficiency of the Np/VEGF complex thus prepared, 50 - 300 nm in size, were 1.87% y. RT-PCR and ELISA showed that VEGF gene had been successfully transfected into myocardial cells by the nanoparticles. A great number of nanoparticles were observed in the myocardial cytoplasm and nuclei. One month after operation, the ventricular wall motor amplitude of the Np/VEGF group was 1.87 mm +/- 0.32 mm, significantly larger than those of the blank plasmid group (1.59 mm +/- 0.24 mm, P < 0.05) and control group (0.93 mm +/- 0.40 mm, P < 0.05); and the left ventricular ejection fraction of the Np/VEGF group was 60% +/- 10%, significantly higher than those of the blank plasmid group (50% +/- 6%, P < 0.05) and control group (40% +/- 8%, P < 0.05). The capillary density at low power field (x 100) of the Np/VEGF group was 57 +/- 12, significantly higher than those of the VEGF group (41 +/- 14) and control group (24 +/- 8).CONCLUSION:Nanoparticle can act as a vector to transfect specific gene in vitro and in vivo. Direct gene transfer of nanoparticle with DNA encoding VEGF into the ischemic rabbit myocardium can increase capillary number; therefore it may be a novel therapeutic approach for myocardial ischemia.

SonoVue delivering Ang-1 to ischemic myocardium in acute myocardial infarction

Angiogenin Gene Transfer Improves Left Ventricular Function in Rats with Myocardial Infarction

Transfection of Ang-1 Gene Via Ultrasound-Mediated SonoVue Microbubble Destruction in Vitro and in Vivo

Raav-Mediated Angiogenin Gene Transfer Induces Angiogenesis and Modifies Left Ventricular Remodeling in Rats with Myocardial Infarction

Targeted Transfection of Ang-1 Gene Via Microbubbles Carrying ICAM-1 Antibody to Acute Myocardial Infarction

Targeted Anti-Icam-1 Microbubbles Mediated Hang-1 Gene Transfection in Treatment of Ischemic Myocardium in Rabbits

The effect of ultrasound guided via chest puncture injection and ultrasound targeted microbubble destruction-mediated the Ang1 gene therapy in myocardial infarction canines

Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction–mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines with Acute Myocardial Infarction

Intracoronary Ultrasound Targeted Microbubble Destruction Enhances Angiogenesis in Canine with Acute Myocardial Infarction

[Induction of Angiogenesis in Ischemic Myocardium by Adenovirus Mediated Angiopoietin-1 Gene Transfer, an Experimental Study].

Ultrasound-targeted microbubble destruction-mediated Ang1 gene transfection improves left ventricular structural and sympathetic nerve remodeling in canines with myocardial infarction

Angiogenesis in Rabbit Models with Acute Myocardial Infarction

[Effect of Nanoparticle with Vascular Endothelial Growth Factor Gene Transferred into Ischemic Myocardium: Experiment with Rabbits].

Experimental Study on Treatment of Limb Ischemia in a Rabbit Model by Angiogenin

Ultrasound targeted microbubbles destruction-mediated the Ang1 gene transfection improves left ventricular mechanical synchrony during the progression of myocardial infarction in canines

In Vivo Ultrasound Molecular Imaging of SDF-1 Expression in a Swine Model of Acute Myocardial Infarction.

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium.

Ultrasound-Mediated Microbubble Destruction Enhances Vegf Gene Delivery To The Infarcted Myocardium In Rats

Assessment of Atherosclerotic Plaques in the Rabbit Abdominal Aorta with Interleukin-8 Monoclonal Antibody-Targeted Ultrasound Microbubbles

Comparison of Bone Marrow Mononuclear Cell Implantation with or Without Transfection of Phvegf165 in Improving Infarcted Cardiac Function